Post Profile

A new kind of treatment is working better than chemotherapy in some lung cancer patients (BMY, MRK)

For people with advanced forms of lung cancer, chemotherapy might not be the only — or even the best — option. The drug, marketed as Keytruda, is one of a new set of drugs called immunotherapy. The drug targets the programmed cell death 1 (or PD-1) receptor and allows the body's own immune system go after the cancer cells. Merck, the maker of Keytruda, just finshed a new trial on the drug, for patients who haven't yet been treated for advanced non-small cell lung cancer.
read more


Related Posts

FDA Approves Game-Changing Immunotherapy Drug to Fight Lung Cancer

Health : Newswise Medical News

The U.S. Food and Drug Administration today approved the breakthrough drug Keytruda to treat advanced non-small cell lung cancer, signaling a paradigm shift in the way the deadliest of all cancers is treated.

Lung Cancer Study Focuses on a More Targeted Treatment Option

Health : Newswise Medical News

A new study offered at Houston Methodist Hospital will compare an emerging immunotherapy drug to an existing chemotherapy drug and look at the effects both drugs have on the development of non-small cell lung cancer, a type of cance...

New immunotherapy drug outperforms chemotherapy for a form of lung cancer

Health : The Checkup

CHICAGO — A new drug that unleashes the body's immune system on cancer cells performed better than a traditional chemotherapy agent in fighting an advanced form of lung cancer, researchers reported Friday. The new drug was also less...

No silver lining in failed Bristol cancer drug trial

Health : Reuters: Health

COPENHAGEN (Reuters) - Bristol-Myers Squibb disappointed investors on Sunday as researchers detailed data for its Opdivo cancer immunotherapy, which was already known to have failed to do better than older chemotherapies in a closel...

Immunotherapy drug a 'gamechanger' for head and neck cancer

Health : The Guardian: Health

Nivolumab found to extend lives of relapsed patients who had run out of therapy options An immunotherapy drug hailed as a potential “gamechanger” in the treatment of cancer could soon offer new hope to patients with currently untrea...


Copyright © 2016 Regator, LLC